Pharma & Biotech
Good times in the City, as evidenced by finnCap raising profits guidance. Meanwhile, the IPOs are starting...
Advanced Oncotherapy looks forward to making LIGHT cancer treatment fully operational
Verona Pharma looks forward to phase III ensifentrine trials after US$200mln fundraise
Maxcyte: At the forefront of cell therapy revolution
Only registered members can use this feature.
© Proactive 2021.
Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority. Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.